EAU 2018: Risk Factors of Short-Term Surgical Retreatment After Greenlight Laser Therapy for Benign Prostate Hyperplasia: A Multi-Institutional Analysis
After a comprehensive database search, 777 patients met the inclusion criteria, of which 32 patients (4.1%) had a repeat procedure for obstruction within the first year of PVP for BPH. Of these 32 patients, 3 underwent secondary PVP, 8 TURP, 11 EU, and 10 BNR. Data analysis was split into patients with no follow up surgery (n=745) and patients who did have follow up surgery (n=32). Between these two groups, patient demographics, disease characteristics, functional questionnaires (International Prostate Symptom Score (IPSS) and Quality of Life), and operative laser parameters were not significantly different. However, patient age, operative laser features, and IPSS improvement were significantly greater in the secondary procedure cohort.
In conclusion, the factors associated with reintervention after Greenlight PVP for the treatment of BPH imply that the impact of surgeon-related features, such as operative laser settings, is the most important determination of functional outcomes of these patients. Operative quality indicators while performing PVP should be standardized during the training process.
Presented by: Dr. I. Ouzaid, Bichat Hospital, Dept. of Urology, Paris, France
Co-Authors: Gerbaud F. 1, Ravery V. 1, Mathieu R. 2 , Lebdai S. 3, Bensalah K. 2, Abdel Rahmene A. 3, Vincendeau S. 2
Author Information:
1. Bichat Hospital, Dept. of Urology, Paris, France
2. CHU Rennes, Dept. of Urology, Rennes, France
3. CHU Angers, Dept. of Urology, Angers, France
Written by: Zachary Valley, Department of Urology, University of California-Irvine at the 2018 European Association of Urology Meeting EAU18, 16-20 March, 2018 Copenhagen, Denmark